Abstract
This descriptive research study was aimed at assessing the progress of antivirus
treatment, the difference in CD4 related antivirus treatment formulation before and after
treatment. The sample population comprised cases of HIV/AIDS who were treated at
Wanghin Hospital, Srisaket Province in the period from 2003 to July 31, 2007. The study
used secondary data on 89 cases of HIV/AIDS. Data analysis was carried out by using a
computer program. The mean difference was calculated by chi-square, t-test and paired
t-test. The samples comprised male patients (52.8%), female patients (47.2%); and 56.2 percent of the samples were aged 31-40 years. The CD4 counts in the five-year period
exceeding 200 cells/mm3 were 35.5, 40.0, 60.7, 65.5 and 84.4, respectively. There were two
antivirus treatment formulas, i.e., GPO vir, which was used in 80.9 percent of the cases,
and the formula of D4T, 3TC and Efavirenz in 19.1 percent of them. There was no difference
in the CD4 count between the two drug formulations, but the differences were significant
at the 0.001 level between, after and before treatments. CD4 cells exceeding 200
cells/mm3 were found in 93.8 percent of the female patients and in 75 percent of the male
patients, which was significantly differnt (p< 0.05). Based on the present research, it is
recommended that the patients should receive drugs continuously and follow-up, evaluation,
and patient care should be provided continuously.
